Homburger advised CDR-Life in the transaction.CDR-Life Inc, a Swiss biotechnology company pioneering a new and differentiated class of highly tumor-specific immune-oncology therapeutics, announced the closing of…
CDR-Life Inc’s $76 Million Series A Financing Round
